CDH Investments Leads Series B Round In Chinese Gene Firm Vision Medicals

Vision Medicals, a Chinese gene technology and precision medicine company, recently announced the completion of a RMB200 million (US$28.75 million) series B round financing, led by CDH Investments, with participation from CICC Qichen, Cash Capital, and Volcanics Venture.

Proceeds of the round will be mainly used for product development and upgrading, national clinical inspection network construction, medical device product registration, industrial base construction, and strengthening of medical brand marketing and clinical services.

Founded in 2018, Vision Medicals focuses on genetic technology and precision medicine. The company has two core technology platforms: metagenomics next generation sequencing(mNGS) diagnosis and gene editing tool (CRISPR-Cas12/13) rapid diagnosis technology.

Vision Medicals has established more than 5000 square meters of medical testing laboratories, R&D centers, in-vitro diagnostic equipment and reagent GMP production bases in Beijing, Nanjing, Shanghai, Guangzhou and other places, and now is working closely with Chinese top hospitals to create a big data and artificial intelligence diagnosis system.

“The application of metagenomics technology to pathogen detection has solved the unmet clinical needs, especially in the context of the global outbreak of COVID-19 epidemic this year. Whether for monitoring the epidemic or the diagnosis of complex infections., it has produced huge social value,” said Wang Lin, founding partner of CDH Investments.

Guangzhou-based Vision Medicals raised RMB100 million led by Volcanics Ventures and Cash Capital in a series A round in 2019.

China Expert Network
 
China Money AI
Introducing Finley, the fintech newsbot from China Money Network! Using state-of-the-art machine learning technologies, Finley scours the globe for immediately usable data about the latest private equity deals, venture capital funding rounds, and business expansions happening in China. Finley asks: Who's buying whom? What company just raised new capital? What is the relationship among the parties? Then Finley uses his very real artificial intelligence to decipher that unstructured data to write news articles for you to read. So from unstructured data to a news story you can understand, China Money Network's Finley is your fintech newsbot business partner!

LEAVE A REPLY